VF
RGNX icon

Virtu Financial’s Regenxbio RGNX Stock Holding History

Virtu Financial’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,614
Closed -$97K – 2142
2026
Q1 		$97K Buy
+11,614
New +$122K ﹤0.01% 1198
2025
Q3 		– Sell
-29,543
Closed -$243K – 1983
2025
Q2 		$243K Buy
+29,543
New +$247K 0.01% 842
2024
Q1 		– Sell
-20,988
Closed -$377K – 1979
2023
Q4 		$377K Buy
+20,988
New +$370K 0.03% 504
2021
Q1 		– Sell
-9,698
Closed -$440K – 1953
2020
Q4 		$440K Buy
+9,698
New +$339K 0.05% 477
2017
Q4 		– Sell
-37,417
Closed -$1.23M – 2901
2017
Q3 		$1.23M Buy
+37,417
New +$842K 0.06% 355

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Virtu Financial's RGNX Position: Q2 2026 in Review

Virtu Financial sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 11,614 shares — an estimated $97K sold.

Virtu Financial first reported a position in RGNX in Q3 2017 and held it in 5 quarters. The position peaked at $1.23M in Q3 2017. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Virtu Financial reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 11,614 Regenxbio shares in Q2 2026, an estimated $97K.
  • Virtu Financial first reported a position in Regenxbio in Q3 2017 and held it in 5 quarters.
  • Virtu Financial's Regenxbio position peaked at $1.23M in Q3 2017.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.